Literature DB >> 27566818

Killer Cell Lectin-like Receptor G1 Inhibits NK Cell Function through Activation of Adenosine 5'-Monophosphate-Activated Protein Kinase.

Bojana Müller-Durovic1, Alessio Lanna1,2, Luciana Polaco Covre1,3, Rachel S Mills1, Sian M Henson4, Arne N Akbar1.   

Abstract

NK cells are the first line of defense against infected and transformed cells. Defective NK cell activity was shown to increase susceptibility for viral infections and reduce tumor immune-surveillance. With age, the incidence of infectious diseases and malignancy rises dramatically, suggesting that impaired NK cell function might contribute to disease in these individuals. We found an increased frequency of NK cells with high expression of the inhibitory killer cell lectin-like receptor G1 (KLRG1) in individuals >70 y. The role of KLRG1 in ageing is not known, and the mechanism of KLRG1-induced inhibition of NK cell function is not fully understood. We report that NK cells with high KLRG1 expression spontaneously activate the metabolic sensor AMP-activated protein kinase (AMPK) and that activation of AMPK negatively regulates NK cell function. Pre-existing AMPK activity is further amplified by ligation of KLRG1 in these cells, which leads to internalization of the receptor and allows interaction with AMPK. We show that KLRG1 activates AMPK by preventing its inhibitory dephosphorylation by protein phosphatase-2C rather than inducing de novo kinase activation. Finally, inhibition of KLRG1 or AMPK prevented KLRG1-induced activation of AMPK and reductions in NK cell cytotoxicity, cytokine secretion, proliferation, and telomerase expression. This novel signaling pathway links metabolic sensing, effector function, and cell differentiation with inhibitory receptor signaling that may be exploited to enhance NK cell activity during ageing.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27566818      PMCID: PMC5027915          DOI: 10.4049/jimmunol.1600590

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  Dissecting the role of 5'-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase.

Authors:  Marianne Suter; Uwe Riek; Roland Tuerk; Uwe Schlattner; Theo Wallimann; Dietbert Neumann
Journal:  J Biol Chem       Date:  2006-08-30       Impact factor: 5.157

2.  NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation.

Authors:  Nicholas D Huntington; Hy Tabarias; Kirsten Fairfax; Jason Brady; Yoshihiro Hayakawa; Mariapia A Degli-Esposti; Mark J Smyth; David M Tarlinton; Stephen L Nutt
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

3.  KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells.

Authors:  Sian M Henson; Ornella Franzese; Richard Macaulay; Valentina Libri; Rita I Azevedo; Sorena Kiani-Alikhan; Fiona J Plunkett; Joanne E Masters; Sarah Jackson; Stephen J Griffiths; Hans-Peter Pircher; Maria V D Soares; Arne N Akbar
Journal:  Blood       Date:  2009-04-30       Impact factor: 22.113

4.  Cutting edge: inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells.

Authors:  Scott H Robbins; Khuong B Nguyen; Nobuaki Takahashi; Toshifumi Mikayama; Christine A Biron; Laurent Brossay
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

5.  NK phenotypic markers and IL2 response in NK cells from elderly people.

Authors:  F Borrego; M C Alonso; M D Galiani; J Carracedo; R Ramirez; B Ostos; J Peña; R Solana
Journal:  Exp Gerontol       Date:  1999-04       Impact factor: 4.032

6.  Different inhibitory capacities of human and mouse KLRG1 are linked to distinct disulfide-mediated oligomerizations.

Authors:  Maike Hofmann; Oliver Schweier; Hanspeter Pircher
Journal:  Eur J Immunol       Date:  2012-07-27       Impact factor: 5.532

7.  Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults.

Authors:  Charles T Lutz; Anush Karapetyan; Ahmad Al-Attar; Brent J Shelton; Kimberly J Holt; Jason H Tucker; Steven R Presnell
Journal:  J Immunol       Date:  2011-03-14       Impact factor: 5.422

Review 8.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1).

Authors:  Qin Ouyang; Wolfgang M Wagner; David Voehringer; Anders Wikby; Tatjana Klatt; Steffen Walter; Claudia A Müller; Hanspeter Pircher; Graham Pawelec
Journal:  Exp Gerontol       Date:  2003-08       Impact factor: 4.032

10.  Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1).

Authors:  David Voehringer; Marie Koschella; Hanspeter Pircher
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

View more
  33 in total

Review 1.  Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function.

Authors:  Sophie M Poznanski; Nicole G Barra; Ali A Ashkar; Jonathan D Schertzer
Journal:  Inflamm Res       Date:  2018-07-31       Impact factor: 4.575

2.  Compartmentalized cytotoxic immune response leads to distinct pathogenic roles of natural killer and senescent CD8+ T cells in human cutaneous leishmaniasis.

Authors:  Luciana Polaco Covre; Oliver Patrick Devine; Renan Garcia de Moura; Milica Vukmanovic-Stejic; Reynaldo Dietze; Rodrigo Ribeiro-Rodrigues; Herbert Leonel de Matos Guedes; Raphael Lubiana Zanotti; Aloisio Falqueto; Arne N Akbar; Daniel Claudio Oliveira Gomes
Journal:  Immunology       Date:  2020-01-26       Impact factor: 7.397

3.  B Cell-Specific Biomarkers for Optimal Antibody Responses to Influenza Vaccination and Molecular Pathways That Reduce B Cell Function with Aging.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

4.  High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunity.

Authors:  Tom Erkers; Bryan J Xie; Laura J Kenyon; Brian Smith; Mary Rieck; Kent P Jensen; Xuhuai Ji; Marina Basina; Samuel Strober; Robert S Negrin; Holden T Maecker; Everett H Meyer
Journal:  Blood       Date:  2020-03-12       Impact factor: 22.113

Review 5.  Senescent B cells in aging and age-related diseases: Their role in the regulation of antibody responses.

Authors:  Daniela Frasca
Journal:  Exp Gerontol       Date:  2017-07-04       Impact factor: 4.032

6.  Soluble Antigen Arrays Efficiently Deliver Peptides and Arrest Spontaneous Autoimmune Diabetes.

Authors:  Rebuma Firdessa-Fite; Stephanie N Johnson; Martin A Leon; Mohsen Khosravi-Maharlooei; Rocky L Baker; Joshua O Sestak; Cory Berkland; Remi J Creusot
Journal:  Diabetes       Date:  2021-01-19       Impact factor: 9.337

7.  Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.

Authors:  Luca Antonioli; Carolina Pellegrini; Matteo Fornai; Laura Benvenuti; Vanessa D'Antongiovanni; Rocchina Colucci; Lorenzo Bertani; Clelia Di Salvo; Giorgia Semeghini; Concettina La Motta; Laura Giusti; Lorenzo Zallocco; Maurizio Ronci; Luca Quattrini; Francesco Angelucci; Vito Coviello; Won-Keun Oh; Quy Thi Kim Ha; Zoltan H Németh; Gyorgy Haskó; Corrado Blandizzi
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

Review 8.  Divergent Sepsis Pathophysiology in Older Adults.

Authors:  Meagan S Kingren; Marlene E Starr; Hiroshi Saito
Journal:  Antioxid Redox Signal       Date:  2021-10-01       Impact factor: 8.401

9.  NK and NKT cells have distinct properties and functions in cancer.

Authors:  Xia Liu; Lingyun Li; Fusheng Si; Lan Huang; Yangjing Zhao; Chenchen Zhang; Daniel F Hoft; Guangyong Peng
Journal:  Oncogene       Date:  2021-06-12       Impact factor: 9.867

10.  Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers.

Authors:  Angela Tata; Garvin Dodard; Céline Fugère; Corinne Leget; Mélody Ors; Benjamin Rossi; Eric Vivier; Laurent Brossay
Journal:  Oncoimmunology       Date:  2021-06-15       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.